TheStreetSweeper issues negative report on PlasmaTech Biopharma (NASDAQ: PTBI).From the Report:This Dallas biotech has rocketed on “news” of “orphan drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE